These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4168957)

  • 21. [Significance of the isoniazid inactivation in the therapy of pulmonary tuberculosis].
    Gol'dshteĭn VD; Ioffe RA; Ponomareva ES
    Probl Tuberk; 1970; 48(1):34-9. PubMed ID: 5425443
    [No Abstract]   [Full Text] [Related]  

  • 22. [Problems of therapeutic management of patients with pulmonary tuberculosis excreting tuberculous mycobacteria resistent to streptomycin and phthivazid].
    Vinnik LA
    Probl Tuberk; 1966; 44(6):23-7. PubMed ID: 4968673
    [No Abstract]   [Full Text] [Related]  

  • 23. [Criteria and methods for determination of the HINA preparations inactivation].
    Smirnov GA
    Probl Tuberk; 1972; 50(4):54-61. PubMed ID: 5063046
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative value of tubazid, larusan and preparation INKh-17].
    Smirnov GA; Efremova ZR; Galkeeva TN
    Probl Tuberk; 1970; 48(4):29-36. PubMed ID: 5471127
    [No Abstract]   [Full Text] [Related]  

  • 25. Isoniazid inactivation in tuberculous patients: a comparative study by vertical diffusion and tube dilution methods.
    Sen PK; Saha JR; Chatterjee R
    Indian J Med Res; 1972 Jan; 60(1):19-27. PubMed ID: 4623944
    [No Abstract]   [Full Text] [Related]  

  • 26. [Levels of isonicotinic acid amide in patients with pulmonary tuberculosis treated with isonicotinic acid hydrazide and ethionamide].
    Sosnowski W; Rozniecki J; Podoska M; Galamon T
    Gruzlica; 1970 Oct; 38(11):1089-95. PubMed ID: 4249764
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experience with fenazid in perperas with respiratory tuberculosis and post-tuberculous changes in the lung].
    Stakhanov VA; Makarov OV; Kaiukova SI; Chernousova LN; Borisova MI; Slastnikova EB
    Probl Tuberk Bolezn Legk; 2004; (2):45-8. PubMed ID: 15137130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The influence of the simultaneous administration of 5-bromosalicylohydroxamic acid (T-40) and isonicotinic acid hydrazide on the concentration of free isonicotinic acid hydrazide in the urine of patients with pulmonary tuberculosis].
    Zduńczyk-Pawelek H; Otrzonsek N; Kostrzewska K
    Gruzlica; 1965 May; 33(5):411-5. PubMed ID: 5319220
    [No Abstract]   [Full Text] [Related]  

  • 29. Newborn infants of tuberculous mothers, further comment.
    Cohen SN; Weber WW
    Pediatrics; 1969 Feb; 43(2):303-4. PubMed ID: 5304286
    [No Abstract]   [Full Text] [Related]  

  • 30. Elimination kinetics of isoniazid in the newborn infant.
    Miceli JN; Olson WA; Cohen SN
    Dev Pharmacol Ther; 1981; 2(4):235-9. PubMed ID: 7196317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Incompatibility of dilantin with isonicotinic acid hydrazides].
    Karlov VA
    Klin Med (Mosk); 1973 Sep; 51(9):118-20. PubMed ID: 4791326
    [No Abstract]   [Full Text] [Related]  

  • 32. [Significance of the inactivation of isonicotinic acid hydrazide preparations in the therapy of recent cases of pulmonary tuberculosis].
    SMIRNOV GA
    Ter Arkh; 1963 Mar; 35():63-70. PubMed ID: 13993079
    [No Abstract]   [Full Text] [Related]  

  • 33. [Inactivation of INH and effectiveness of chemotherapy in pulmonary tuberculosis].
    Gipp ZI
    Vrach Delo; 1974 Jan; (1):104-5. PubMed ID: 4468550
    [No Abstract]   [Full Text] [Related]  

  • 34. Diphenylhydantoin intoxication attendant to slow inactivation of isoniazid.
    Brennan RW; Dehejia H; Kutt H; McDowell F
    Neurology; 1968 Mar; 18(3):283. PubMed ID: 5690351
    [No Abstract]   [Full Text] [Related]  

  • 35. Isoniazid inactivators.
    J Assoc Physicians India; 1978 May; 26(5):440-2. PubMed ID: 730724
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of isoniazid and of a complex compound of cobalt with pyridoxine on rabbits infected with tuberculosis].
    Sodikov ES; Gapon'ko LA
    Farmakol Toksikol; 1972; 35(2):234-7. PubMed ID: 5017977
    [No Abstract]   [Full Text] [Related]  

  • 37. [Blood bacteriostatic activity in patients depending on the type of inactivation of isonicotinic acid hydrazide in the body].
    Gil'madinova RSh; Bakanova DIa
    Antibiotiki; 1971 Jan; 16(1):87-90. PubMed ID: 4994900
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of inactivation of drugs of the HINA and PAS group on the effectiveness of antibacterial therapy in renal tuberculosis].
    Tkachuk VN; Miloradovich VM; Shenderova RI
    Probl Tuberk; 1976; 3():50-2. PubMed ID: 967858
    [No Abstract]   [Full Text] [Related]  

  • 39. [Inactivation of isonicotinic acid hydrazide and of its derivative phthivazide in organisms of various animals].
    GREBENNIK LI; MAKEEVA OO
    Farmakol Toksikol; 1960; 23():546-9. PubMed ID: 13708113
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of insulin on isoniazid and para-aminosalicylic acid metabolism in patients with pulmonary tuberculosis].
    Savula MM; Kiselova ES
    Probl Tuberk; 1974; (8):43-6. PubMed ID: 4409368
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.